Location History:
- Kanagawa, JP (1995)
- Nitta-machi, JP (2006)
- Gunma, JP (2006 - 2017)
- Ohra-gun, JP (2008 - 2018)
Company Filing History:
2 out of 5 
1 out of 439 
1 out of 19 
Years Active: 1995-2018
Title: **Yoshiharu Minamitake: Innovations in Peptide Research**
Introduction
Yoshiharu Minamitake is an esteemed inventor based in Gunma, Japan. With a remarkable portfolio of 10 patents, he has made significant contributions to the field of peptide research, particularly focusing on compounds that induce the secretion of growth hormones.
Latest Patents
One of Minamitake's notable inventions includes modified ghrelin peptides. This innovation provides a peptide-type compound designed to induce the secretion of growth hormone while also increasing the intracellular calcium ion concentration. His work includes the incorporation of at least one modified amino acid and/or a non-amino acid compound, or a pharmaceutically acceptable salt thereof. This patent addresses vital aspects of growth hormone regulation, promising potential advancements in medicinal applications.
Career Highlights
Minamitake has worked with influential organizations, including Daiichi Asubio Pharma Co., Ltd., where he contributed to significant research initiatives. His extensive experience in the biotechnology field underscores his role as a pioneer in peptide innovation.
Collaborations
Throughout his career, Minamitake has collaborated with notable professionals such as Hisayuki Matsuo and Kenji Kangawa. These partnerships have facilitated the advancement of his research and the successful development of his patented innovations.
Conclusion
Yoshiharu Minamitake's contributions to peptide research and his innovative patents reflect his dedication to advancing the field of biochemistry. His ongoing work continues to influence therapeutic applications, showcasing the importance of innovation in science and medicine.